We are here to help you get your questions answered. If you can’t find the answer you are looking for here, contact AfrezzaAssist℠ for help.
We are here to help you get your questions answered. If you can’t find the answer you are looking for here, contact AfrezzaAssist℠ for help.
Afrezza® is a man-made insulin that is breathed in through your lungs (inhaled) and is used to control high blood sugar in adults with type 1 or type 2 diabetes. Afrezza® is not for use in place of basal insulin. Afrezza® must be used with basal insulin in people who have type 1 diabetes mellitus. Afrezza® is not for use to treat diabetic ketoacidosis. Afrezza® is not for use in people with chronic lung disease such as asthma and COPD. It is not known if Afrezza® is safe and effective for use in people who smoke. Afrezza® is not for use in people who smoke or have recently stopped smoking (less than 6 months). It is not known if Afrezza® is safe and effective in children under 18 years of age.
Afrezza® is inhaled at the beginning of a meal. After you inhale Afrezza®, the insulin passes quickly through your lungs and into your bloodstream, where it begins reducing blood sugars.
Afrezza® is most active between 35–45 minutes and stops lowering blood glucose after 1.5 to 3 hours, depending on the dose.* Check with your healthcare provider on how frequently he or she wants you to monitor your blood sugar. You may need to take an additional dose of Afrezza® to achieve your optimal blood sugar control.
*For the 4-unit and 12-unit cartridges, respectively.
Afrezza® is unique because it is the only ultra rapid-acting inhaled insulin available. It starts working quickly without the need for injections at mealtime. Once you breathe Afrezza® into your lungs using the inhaler, insulin appears in your bloodstream in less than 1 minute and it starts controlling blood sugar in about 12 minutes. Afrezza® stops lowering blood glucose after 1.5 to 3 hours, depending on the dose.*
*for the 4-unit and 12-unit cartridges, respectively.
If you have type 1 diabetes, you will still need to take a basal insulin for your basal needs depending on what you and your healthcare provider decide. Your healthcare provider may prescribe Afrezza® to treat mealtime spikes in blood sugar. If you are living with type 2 diabetes, your healthcare provider may consider adjustments to your other diabetes medications if they prescribe Afrezza®.
Afrezza® can be taken with oral diabetes medicines. Be sure to tell your healthcare provider about all other medicines and supplements you are taking because they can affect the way your insulin works.
Afrezza® is an ultra rapid-acting inhaled insulin used to control blood sugar in adults with type 1 or type 2 diabetes. It is not for people with certain types of lung disease (such as asthma or COPD) or who smoke. Do not use Afrezza® if you are allergic to regular human insulin or any of the ingredients in Afrezza®. Afrezza® is not for children under 18 years of age. Consult with your healthcare provider to determine if Afrezza® is right for you.
The most common side effects of Afrezza® include low blood sugar (hypoglycemia), cough, and sore throat or throat irritation.
Before starting Afrezza®, your healthcare provider will give you a breathing test to check how your lungs are working. Your healthcare provider may test again at 6 months and once a year after that. Afrezza® can cause serious side effects, including sudden lung problems (bronchospasms). Do not use Afrezza® if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD).
Yes. Upscript*, a telemedicine platform, lets you talk to a healthcare provider to see if Afrezza® is right for you, from the comfort of your home. Start your journey today.
You can get Afrezza® from any pharmacy. However, some pharmacies may not keep Afrezza® in stock and will need to order it. Once ordered, it will usually arrive at the pharmacy within 1–2 days.
Contact AfrezzaAssist℠ to speak with one of our Patient Support Guides:
MONDAY-FRIDAY, 8 AM-8 PM ET
Use our Find a Doctor Tool here.
Nationally, over 70% of patients covered by commercial insurance have access to Afrezza®, but everyone’s coverage is different. The best way to know if your plan covers Afrezza® is to call your insurance provider or contact one of our Patient Support Guides and they can help you understand your insurance coverage:
1-844-323-7399
MONDAY-FRIDAY, 8 AM-8 PM ET
Every federally insured patient’s coverage is different. The best way to know your individual options is by calling your insurance provider or one of our Patient Support Guides. MannKind is committed to helping patients access Afrezza®. For more information, contact AfrezzaAssist℠:
1-844-323-7399
MONDAY-FRIDAY, 8 AM-8 PM ET
Contact AfrezzaAssist℠ to speak to one of our Patient Support Guides:
1-844-323-7399
MONDAY-FRIDAY, 8 AM-8 PM ET
If you have commercial insurance, you may be eligible for the Afrezza® Savings Card Program and pay as little as $35 per month for your prescription. Eligibility criteria and program limits apply. If your insurance doesn’t cover Afrezza®, solutions may exist to help offset the cost. Contact AfrezzaAssist℠ for more information:
MONDAY-FRIDAY, 8 AM-8 PM ET
Visit www.afrezzasavingscard.com to enroll and download your card.
Contact AfrezzaAssist℠ to speak to one of our Patient Support Guides:
MONDAY-FRIDAY, 8 AM-8 PM ET
Since Afrezza® is an inhaled powder, it is not uncommon to experience a cough at the beginning of your treatment. It is important to take Afrezza at room temperature. Having a sip of water before and after inhalation may also help. In the clinical studies, coughs were mild and typically declined with continued use after 1-4 weeks. If you develop a persistent or recurring cough, or have breathing difficulties while using Afrezza®, contact your healthcare provider.
A small portion of the inhaled dose of Afrezza® may be exhaled and may produce a visible cloud. This is entirely normal and expected and does not indicate a problem with administration. To learn proper inhalation technique, refer to the Instructions for Use or click here.
A small amount of powder residue in the mouthpiece or cartridge is normal. This does not affect your dose.
A small amount of powder residue in the mouthpiece or cartridge is normal. This does not affect your dose. Be sure to replace the inhaler every 15 days and continue to monitor your blood sugar.
Take Afrezza® exactly as your healthcare provider tells you to. Your healthcare provider should tell you how much Afrezza® to use and when to use it. Read the detailed Instructions for Use that comes with each carton/box/package of Afrezza®.
If you are still seeing high blood sugars after taking Afrezza®, it could be something related to inhalation technique, a dose requiring adjustment, or day-to-day variability of food and your body. You should consult with your healthcare provider. Dosing on Afrezza® is typically a two-step process with your healthcare provider: determining an initial dose and then adjusting as needed. During the first few days, it’s helpful to see how your body responds, and to talk to your healthcare provider to see if you need to adjust your dose of Afrezza® to achieve your optimal blood sugar control. Check with your healthcare provider on how frequently he or she wants you to monitor your blood sugar.
If you are sick, your insulin needs may change, so work with your healthcare provider to determine what type of dose adjustments would be right for you. Before you make any changes, consult with your healthcare provider.
Afrezza® is a mealtime insulin and is recommended to be taken at the beginning of the meal. Talk to your doctor about missed doses, and they will help you find an appropriate time to take Afrezza® based on your individual needs and goals.
While not in use, Afrezza® should be stored in the refrigerator just like any insulin. However, if you are traveling and don’t have access to a refrigerator, unopened blister cards or strips can be stored at room temperature for up to 10 days. After the foil is punctured, the cartridges can be stored at room temperature for up to three days. You should not put Afrezza® back into the refrigerator after it has been stored at room temperature. It should never be stored in the freezer. If you have questions about travelling with Afrezza®, contact AfrezzaAssist℠ to speak to one of our Patient Support Guides:
1-844-323-7399
MONDAY-FRIDAY, 8 AM-8 PM ET
Do not wash the Afrezza® Inhaler. You can wipe the mouthpiece with a clean, dry cloth to remove moisture or lipstick.
Look on your box or on the foil wrapper to check the expiration date.
Contact AfrezzaAssist℠:
1-844-323-7399
MONDAY-FRIDAY, 8 AM-8 PM ET
If you need more information or help, please visit the Taking Afrezza® page or contact AfrezzaAssist℠:
1-844-323-7399
MONDAY-FRIDAY, 8 AM-8 PM ET
Tell us a little about yourself and we’ll send you information and resources.
*Third-party website; does not constitute an endorsement or recommendation by MannKind Corporation.
References:
US-AFR-1815
AFREZZA is a man-made insulin that is breathed-in through your lungs (inhaled) and is used to control high blood sugar in adults with diabetes mellitus.
What is the most important information I should know about AFREZZA? AFREZZA can cause serious side effects, including:
Sudden lung problems (bronchospasms). In a study, some AFREZZA-treated patients with asthma, whose asthma medication was temporarily withheld, experienced sudden lung problems. Do not use AFREZZA if you have long-term (chronic) lung problems such as asthma or chronic obstructive pulmonary disease (COPD). Before starting AFREZZA, your healthcare provider will give you a breathing test to check how your lungs are working.
Do not use Afrezza® if you:
Before using Afrezza®, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins or herbal supplements.
Before you start using Afrezza®, talk to your healthcare provider about low blood sugar and how to manage it.
While using Afrezza® do not:
Afrezza® may cause serious side effects that can lead to death, including:
See “What is the most important information I should know about Afrezza®?”
Treatment with TZDs and Afrezza® may need to be changed or stopped by your healthcare provider if you have new or worse heart failure.
Get emergency medical help if you have:
• Trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, confusion.
The most common side effects of Afrezza® include:
These are not all the possible side effects of Afrezza®. Call your doctor for medical advice about side effects.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088 (1-800-332-1088).
Please See Full Prescribing Information, including BOXED WARNING, Medication Guide and Instructions for Use for AFREZZA.
AFREZZA, the Afrezza logo, AFREZZAASSIST, AFREZZAASSIST and logo, MANNKIND, and BLUHALE VIS are registered trademarks of MannKind Corporation. © 2024 MannKind Corporation.
This site is intended for use by U.S. residents only.
Complete a quick medical questionnaire to help determine if Afrezza is right for you.
Schedule an appointment with a licensed healthcare provider.
If Afrezza is right for you, pick it up from your local pharmacy or have it delivered to your home.
You are now leaving Afrezza.com
By clicking “Yes” below, you acknowledge and agree that MannKind does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. MannKind makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. MannKind recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. MANNKIND AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE.
If you agree to the above, click “YES” to proceed to the third-party website. If you do not agree to the above, click “NO” to remain on Afrezza.com.